1. Home
  2. AVO vs CRVS Comparison

AVO vs CRVS Comparison

Compare AVO & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mission Produce Inc.

AVO

Mission Produce Inc.

HOLD

Current Price

$13.09

Market Cap

1.2B

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.96

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVO
CRVS
Founded
1983
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
AVO
CRVS
Price
$13.09
$14.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$17.00
$30.17
AVG Volume (30 Days)
1.5M
1.5M
Earning Date
06-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
1.92
48.04
EPS
N/A
N/A
Revenue
$1,391,200,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.68
N/A
52 Week Low
$10.07
$3.96
52 Week High
$15.53
$26.95

Technical Indicators

Market Signals
Indicator
AVO
CRVS
Relative Strength Index (RSI) 59.93 57.18
Support Level $13.03 $14.24
Resistance Level $14.28 $16.85
Average True Range (ATR) 0.49 0.81
MACD 0.10 0.05
Stochastic Oscillator 67.99 56.33

Price Performance

Historical Comparison
AVO
CRVS

About AVO Mission Produce Inc.

Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: